Kedrion Biopharma
Francesco Acampora has a diverse work experience in the pharmaceutical industry. Starting with an internship at inticom spa in 2010, they then moved on to roles at Biotest Italia s.r.l., where they progressed from Brand Manager to Marketing Manager for East & South Europe. Francesco later transitioned to Biotest AG, taking on roles such as Area Manager for East & South Europe and Regional Director for APAC & Indian Subcontinent. Francesco'smost recent role was Sales Director at Biotest Italia s.r.l. before becoming Sales & Marketing Director for Italy at Kedrion Biopharma in 2024.
Francesco Acampora holds a Bachelor's degree in Business Economics from the Seconda Università degli Studi di Napoli, which they obtained in 2011. Francesco further pursued their education at the same university and completed a Master's degree in Economics and Management with a profile in Marketing in 2013. In 2015, they attended Sole24Ore Business School for a specialized program in Marketing & Digital Communication.
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.